Big Move For China SXT Pharmaceuticals, Inc.
Mon, Feb 03, 2020 at 05:30 PM
China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ) rocketted at $1.44, representing a gain of 45.5%. The stock appeared on our News Catalysts scanner on Thu 16 Jan 20 at 09:22 AM in the 'RECOMMENDATION' category. From Fri 10 Jan 20, the stock recorded 42.86% Up Days and 33.33% Green Days
About China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ)
China SXT Pharmaceuticals Inc is engaged in the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces(TCMP). The company sells Advanced TCMP, Fine TCMP, and Regular TCMP. Generating a majority of its revenue from the Advanced TCMP. Geographically, the firm generates a majority of its revenue from the People's Republic of China.
Top 10 Gainers:
- China Pharma Holdings, Inc. (CPHI:NYSEMKT), 96.46%
- Gulf Resources, Inc. (GURE:NASDAQ), 50.71%
- China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ), 45.45%
- OpGen, Inc. (OPGN:NASDAQ), 44.59%
- Insmed Incorporated (INSM:NASDAQ), 40.6%
- Four Seasons Education (Cayman) Inc. (FEDU:NYSE), 28.46%
- Shineco, Inc. (TYHT:NASDAQ), 28.07%
- Vaxart, Inc. (VXRT:NASDAQ), 28%
- AIM ImmunoTech Inc. (AIM:NYSEMKT), 25.14%
- BIO-key International, Inc. (BKYI:NASDAQ), 22.7%